nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—ABCB1—Topotecan—cervical cancer	0.546	1	CbGbCtD
Perindopril—SLC15A1—epithelium—cervical cancer	0.0157	0.0572	CbGeAlD
Perindopril—SLC15A1—renal system—cervical cancer	0.0146	0.053	CbGeAlD
Perindopril—SLC15A1—endometrium—cervical cancer	0.0141	0.0513	CbGeAlD
Perindopril—SLC15A1—mammalian vulva—cervical cancer	0.0137	0.0496	CbGeAlD
Perindopril—ACE—epithelium—cervical cancer	0.0113	0.041	CbGeAlD
Perindopril—ACE—decidua—cervical cancer	0.0107	0.0387	CbGeAlD
Perindopril—SLC15A1—vagina—cervical cancer	0.0106	0.0384	CbGeAlD
Perindopril—ACE—renal system—cervical cancer	0.0105	0.038	CbGeAlD
Perindopril—ACE—endometrium—cervical cancer	0.0101	0.0367	CbGeAlD
Perindopril—ACE—mammalian vulva—cervical cancer	0.00979	0.0355	CbGeAlD
Perindopril—SLC15A2—uterine cervix—cervical cancer	0.00976	0.0354	CbGeAlD
Perindopril—SLC15A2—renal system—cervical cancer	0.00913	0.0331	CbGeAlD
Perindopril—SLC15A2—endometrium—cervical cancer	0.00883	0.032	CbGeAlD
Perindopril—ACE—female reproductive system—cervical cancer	0.00839	0.0304	CbGeAlD
Perindopril—BCHE—uterine cervix—cervical cancer	0.00827	0.03	CbGeAlD
Perindopril—ACE—female gonad—cervical cancer	0.00763	0.0277	CbGeAlD
Perindopril—BCHE—endometrium—cervical cancer	0.00748	0.0271	CbGeAlD
Perindopril—SLC15A2—female reproductive system—cervical cancer	0.00731	0.0265	CbGeAlD
Perindopril—Bone pain—Topotecan—cervical cancer	0.00725	0.0407	CcSEcCtD
Perindopril—BCHE—mammalian vulva—cervical cancer	0.00723	0.0263	CbGeAlD
Perindopril—BCHE—uterus—cervical cancer	0.00689	0.025	CbGeAlD
Perindopril—SLC15A2—female gonad—cervical cancer	0.00665	0.0242	CbGeAlD
Perindopril—SLC15A2—vagina—cervical cancer	0.00661	0.024	CbGeAlD
Perindopril—BCHE—female reproductive system—cervical cancer	0.0062	0.0225	CbGeAlD
Perindopril—Ear pain—Topotecan—cervical cancer	0.00591	0.0332	CcSEcCtD
Perindopril—BCHE—vagina—cervical cancer	0.0056	0.0203	CbGeAlD
Perindopril—Anaphylactoid reaction—Topotecan—cervical cancer	0.00521	0.0293	CcSEcCtD
Perindopril—ACE—lymph node—cervical cancer	0.00491	0.0178	CbGeAlD
Perindopril—Cardiac arrest—Topotecan—cervical cancer	0.00479	0.0269	CcSEcCtD
Perindopril—Cramp muscle—Topotecan—cervical cancer	0.00454	0.0255	CcSEcCtD
Perindopril—SLC15A2—lymph node—cervical cancer	0.00428	0.0155	CbGeAlD
Perindopril—Pancytopenia—Topotecan—cervical cancer	0.00414	0.0232	CcSEcCtD
Perindopril—Neutropenia—Topotecan—cervical cancer	0.00407	0.0229	CcSEcCtD
Perindopril—ABCB1—epithelium—cervical cancer	0.00397	0.0144	CbGeAlD
Perindopril—ABCB1—uterine cervix—cervical cancer	0.00394	0.0143	CbGeAlD
Perindopril—Pneumonia—Topotecan—cervical cancer	0.00391	0.022	CcSEcCtD
Perindopril—Stomatitis—Topotecan—cervical cancer	0.00379	0.0213	CcSEcCtD
Perindopril—ABCB1—decidua—cervical cancer	0.00375	0.0136	CbGeAlD
Perindopril—Sweating—Topotecan—cervical cancer	0.00372	0.0209	CcSEcCtD
Perindopril—ABCB1—renal system—cervical cancer	0.00369	0.0134	CbGeAlD
Perindopril—Hepatobiliary disease—Topotecan—cervical cancer	0.00367	0.0206	CcSEcCtD
Perindopril—Epistaxis—Topotecan—cervical cancer	0.00366	0.0206	CcSEcCtD
Perindopril—BCHE—lymph node—cervical cancer	0.00362	0.0132	CbGeAlD
Perindopril—ABCB1—endometrium—cervical cancer	0.00356	0.0129	CbGeAlD
Perindopril—Haemoglobin—Topotecan—cervical cancer	0.00351	0.0197	CcSEcCtD
Perindopril—Rhinitis—Topotecan—cervical cancer	0.0035	0.0196	CcSEcCtD
Perindopril—Haemorrhage—Topotecan—cervical cancer	0.00349	0.0196	CcSEcCtD
Perindopril—Pharyngitis—Topotecan—cervical cancer	0.00346	0.0194	CcSEcCtD
Perindopril—ABCB1—mammalian vulva—cervical cancer	0.00345	0.0125	CbGeAlD
Perindopril—ABCB1—uterus—cervical cancer	0.00328	0.0119	CbGeAlD
Perindopril—Angiopathy—Topotecan—cervical cancer	0.00316	0.0178	CcSEcCtD
Perindopril—Mediastinal disorder—Topotecan—cervical cancer	0.00314	0.0177	CcSEcCtD
Perindopril—Chills—Topotecan—cervical cancer	0.00313	0.0176	CcSEcCtD
Perindopril—Alopecia—Topotecan—cervical cancer	0.00308	0.0173	CcSEcCtD
Perindopril—Malnutrition—Topotecan—cervical cancer	0.00304	0.0171	CcSEcCtD
Perindopril—ABCB1—female reproductive system—cervical cancer	0.00295	0.0107	CbGeAlD
Perindopril—Back pain—Topotecan—cervical cancer	0.00294	0.0165	CcSEcCtD
Perindopril—Muscle spasms—Topotecan—cervical cancer	0.00292	0.0164	CcSEcCtD
Perindopril—Ill-defined disorder—Topotecan—cervical cancer	0.00282	0.0158	CcSEcCtD
Perindopril—Anaemia—Topotecan—cervical cancer	0.00281	0.0158	CcSEcCtD
Perindopril—Angioedema—Topotecan—cervical cancer	0.00277	0.0156	CcSEcCtD
Perindopril—Malaise—Topotecan—cervical cancer	0.00274	0.0154	CcSEcCtD
Perindopril—Leukopenia—Topotecan—cervical cancer	0.00272	0.0153	CcSEcCtD
Perindopril—ABCB1—female gonad—cervical cancer	0.00269	0.00975	CbGeAlD
Perindopril—ABCB1—vagina—cervical cancer	0.00267	0.00969	CbGeAlD
Perindopril—Cough—Topotecan—cervical cancer	0.00265	0.0149	CcSEcCtD
Perindopril—Arthralgia—Topotecan—cervical cancer	0.00258	0.0145	CcSEcCtD
Perindopril—Chest pain—Topotecan—cervical cancer	0.00258	0.0145	CcSEcCtD
Perindopril—Myalgia—Topotecan—cervical cancer	0.00258	0.0145	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00257	0.0144	CcSEcCtD
Perindopril—Discomfort—Topotecan—cervical cancer	0.00255	0.0143	CcSEcCtD
Perindopril—Anaphylactic shock—Topotecan—cervical cancer	0.00248	0.0139	CcSEcCtD
Perindopril—Nervous system disorder—Topotecan—cervical cancer	0.00243	0.0137	CcSEcCtD
Perindopril—Thrombocytopenia—Topotecan—cervical cancer	0.00243	0.0136	CcSEcCtD
Perindopril—Skin disorder—Topotecan—cervical cancer	0.00241	0.0135	CcSEcCtD
Perindopril—Hyperhidrosis—Topotecan—cervical cancer	0.0024	0.0135	CcSEcCtD
Perindopril—Anorexia—Topotecan—cervical cancer	0.00236	0.0133	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00226	0.0127	CcSEcCtD
Perindopril—Paraesthesia—Topotecan—cervical cancer	0.00223	0.0125	CcSEcCtD
Perindopril—Dyspnoea—Topotecan—cervical cancer	0.00221	0.0124	CcSEcCtD
Perindopril—Dyspepsia—Topotecan—cervical cancer	0.00218	0.0123	CcSEcCtD
Perindopril—Decreased appetite—Topotecan—cervical cancer	0.00215	0.0121	CcSEcCtD
Perindopril—Gastrointestinal disorder—Topotecan—cervical cancer	0.00214	0.012	CcSEcCtD
Perindopril—Fatigue—Topotecan—cervical cancer	0.00214	0.012	CcSEcCtD
Perindopril—Pain—Topotecan—cervical cancer	0.00212	0.0119	CcSEcCtD
Perindopril—Constipation—Topotecan—cervical cancer	0.00212	0.0119	CcSEcCtD
Perindopril—Feeling abnormal—Topotecan—cervical cancer	0.00204	0.0115	CcSEcCtD
Perindopril—Gastrointestinal pain—Topotecan—cervical cancer	0.00203	0.0114	CcSEcCtD
Perindopril—Urticaria—Topotecan—cervical cancer	0.00197	0.0111	CcSEcCtD
Perindopril—Abdominal pain—Topotecan—cervical cancer	0.00196	0.011	CcSEcCtD
Perindopril—Body temperature increased—Topotecan—cervical cancer	0.00196	0.011	CcSEcCtD
Perindopril—Asthenia—Topotecan—cervical cancer	0.00178	0.00999	CcSEcCtD
Perindopril—Pruritus—Topotecan—cervical cancer	0.00175	0.00985	CcSEcCtD
Perindopril—ABCB1—lymph node—cervical cancer	0.00173	0.00627	CbGeAlD
Perindopril—Diarrhoea—Topotecan—cervical cancer	0.0017	0.00952	CcSEcCtD
Perindopril—Dizziness—Topotecan—cervical cancer	0.00164	0.00921	CcSEcCtD
Perindopril—Vomiting—Topotecan—cervical cancer	0.00158	0.00885	CcSEcCtD
Perindopril—Rash—Topotecan—cervical cancer	0.00156	0.00878	CcSEcCtD
Perindopril—Dermatitis—Topotecan—cervical cancer	0.00156	0.00877	CcSEcCtD
Perindopril—Headache—Topotecan—cervical cancer	0.00155	0.00872	CcSEcCtD
Perindopril—Nausea—Topotecan—cervical cancer	0.00147	0.00827	CcSEcCtD
